AMRI CEO to Present at the 2013 Wells Fargo Securities Healthcare Conference
ALBANY, N.Y., June 12, 2013
ALBANY, N.Y., June 12, 2013 /PRNewswire/ --AMRI (NASDAQ: AMRI) announced
today that Thomas E. D'Ambra, Ph.D., President and Chief Executive Officer at
AMRI, will present at the 2013 Wells Fargo Securities Healthcare Conference on
Wednesday, June 19, 2013 at 10:40 a.m. ET.
(Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO )
Albany Molecular Research, Inc. (AMRI) is a global contract research and
manufacturing organization offering customers fully integrated drug discovery,
development and manufacturing services. For over 21 years, AMRI has
demonstrated its adaptability as the pharmaceutical and biotechnology
industries have undergone tremendous change in response to multiple
challenges. This experience, a track record of success and locations in the
United States, Europe and Asia now provides our customers with SMARTSOURCING™,
a full range of value-added opportunities providing customers informed
decision-making, enhanced efficiency and more successful outcomes at all
stages of the pipeline. AMRI has also successfully partnered R&D programs and
is actively seeking to out-license its remaining programs for further
development. For more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (@amriglobal).
Contact: Investors - Michael Nolan, AMRI Chief Financial Officer,
518-512-2261; Media - Gina Monari, AMRI Communications, 518-512-2512
Press spacebar to pause and continue. Press esc to stop.